Spruce Biosciences

Biopharmaceutical company that focuses on developing therapies for rare diseases that targets endocrine system

Ticker

SPRB.NASDAQ

Trh

Uzávěrka

10/19/2020

Datum IPO

10/8/2020

Cena umístění

$15

Ziskovost

8.33%

O společnosti

Total Funding

$108M

Spruce Biosciences is a clinical-stage biopharmaceutical focused on developing new treatments for rare endocrine disorders. The company is driven by its mission is to develop meaningful therapies for patients with rare diseases affecting the hypothalamic-pituitary-adrenal. They are committed to transforming the quality of life for patients who have been underserved by scientific innovation.

Number of employees

1 - 10

Headquarters

San Francisco, California, United States